Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More


Fox Chase Cancer Center News

September 27, 2021

Fox Chase Researcher Develops New Methods to Predict Cancer Survival Outcomes by Analyzing Large-Scale Genomic Profiles

PHILADELPHIA (September 27, 2021)—In a recent study, a researcher at Fox Chase Cancer Center outlined new methods for predicting cancer survival and outcomes from studies that utilize large-scale genomic profiling of tumor samples from different cancers.

September 22, 2021

Fox Chase Researchers Evaluate Risks and Benefits Associated With Gastrostomy Tubes in Patients With Cancer

PHILADELPHIA (September 22, 2021)—In a recent study, researchers at Fox Chase Cancer Center examined over 200 patients with gastrostomy tubes and highlighted the need for a multidisciplinary approach to palliative care decision making for cancer patients.

September 22, 2021

Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership

PHILADELPHIA (September 22, 2021)—Salarius Pharmaceuticals Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, today announced a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center. The research, to be carried out by the laboratory of Johnathan Whetstine, PhD, the institute’s director, will help identify new indications and potential biomarkers for Salarius’ lead drug candidate, seclidemstat.

September 21, 2021

Jeffrey M. Farma Appointed State Chair of American College of Surgeons Commission on Cancer

PHILADELPHIA (September 21, 2021)—Jeffrey M. Farma, MD, FACS, chief of the Division of General Surgery at Fox Chase Cancer Center, was appointed as the state chair of the American College of Surgeons Commission on Cancer (CoC) Cancer Liaison Program.

September 20, 2021

Fox Chase Cancer Center Holds Paws for the Cause Dog Walk to Benefit Cancer Research

PHILADELPHIA (September 20, 2021)—Fox Chase Cancer Center will hold its 22nd annual Paws for the Cause dog walk to benefit cancer research as an in-person event this year, along with a two-week virtual event. Both events are hosted by the Fox Chase Board of Associates.

September 20, 2021

Fox Chase Cancer Center Welcomes Dr. Teresa Y. Lee

PHILADELPHIA (September 20, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Teresa Y. Lee, MD, PhD, as an assistant professor. Lee will focus on sarcoma and head and neck cancer.

September 17, 2021

Update on INVICTUS Trial Shows Improved Overall Median Survival in GIST Patients Using Ripretinib

PHILADELPHIA (September 17, 2021)—Results from the phase 3 INVICTUS clinical trial show that the drug ripretinib, also known by its brand name Qinlock, provides clinically meaningful improvement in overall median survival for patients with gastrointestinal stromal tumor (GIST) when compared with placebo.

September 15, 2021

Fox Chase Cancer Center’s Edna Cukierman Offers Commentary in Cancer Research ‘Landmark’ Article

PHILADELPHIA (September 15, 2021)—Fox Chase Cancer Center’s Edna “Eti” Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, recently published a “Landmark” commentary in the journal Cancer Research that explored the impact of a key study.


Connect with Fox Chase